The powerful world of antisense oligonucleotides: From bench to bedside

Antisense oligonucleotides (ASOs) represent a new and highly promising class of drugs for personalized medicine. In the last decade, major chemical developments and improvements of the backbone structure of ASOs have transformed them into true approved and commercialized drugs. ASOs target both DNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Quemener, Anaïs M., Bachelot, Laura, Forestier, Anne, Donnou‐Fournet, Emmanuelle, Gilot, David, Galibert, Marie‐Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Advanced Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285911/
https://www.ncbi.nlm.nih.gov/pubmed/32233021
http://dx.doi.org/10.1002/wrna.1594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285911/
https://www.ncbi.nlm.nih.gov/pubmed/32233021
http://dx.doi.org/10.1002/wrna.1594

Ejemplares similares